Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros

Base de datos
Tipo del documento
Intervalo de año
1.
Int J Environ Res Public Health ; 18(11)2021 06 04.
Artículo en Inglés | MEDLINE | ID: covidwho-1266735

RESUMEN

Soybean koji refers to steamed soybeans inoculated with microbial species. Soybean fermentation improves the health benefits of soybeans. Obesity is a serious health concern owing to its increasing incidence rate and high association with other metabolic diseases. Therefore, we investigated the effects of soybean and soybean koji on high-fat diet-induced obesity in rats. Five-week-old male Sprague-Dawley rats were randomly divided into four groups (n = 8/group) as follows: (1) regular diet (RD), (2) high-fat diet (HFD), (3) HFD + steamed soybean (HFD+SS), and (4) HFD + soybean koji (HFD+SK). SK contained more free amino acids and unsaturated fatty acids than SS. In a rat model of obesity, SK consumption significantly alleviated the increase in weight of white adipose tissue and mRNA expression of lipogenic genes, whereas SS consumption did not. Both SS and SK reduced serum triglyceride, total cholesterol, and low-density lipoprotein cholesterol levels, and increased high-density lipoprotein cholesterol levels. SS and SK also inhibited lipid accumulation in the liver and white adipose tissue and reduced adipocyte size. Although both SS and SK could alleviate HFD-induced dyslipidemia, SK has better anti-obesity effects than SS by regulating lipogenesis. Overall, SK is an excellent functional food that may prevent obesity.


Asunto(s)
Dieta Alta en Grasa , Dislipidemias , Animales , Dieta Alta en Grasa/efectos adversos , Dislipidemias/etiología , Dislipidemias/prevención & control , Hígado , Masculino , Obesidad/etiología , Obesidad/prevención & control , Ratas , Ratas Sprague-Dawley , Glycine max
2.
Nutrients ; 13(2)2021 Feb 05.
Artículo en Inglés | MEDLINE | ID: covidwho-1094259

RESUMEN

Cardiovascular disease (CVD) is the leading cause of death worldwide, claiming over 650,000 American lives annually. Typically not a singular disease, CVD often coexists with dyslipidemia, hypertension, type-2 diabetes (T2D), chronic system-wide inflammation, and obesity. Obesity, an independent risk factor for both CVD and T2D, further worsens the problem, with over 42% of adults and 18.5% of youth in the U.S. categorized as such. Dietary behavior is a most important modifiable risk factor for controlling the onset and progression of obesity and related disease conditions. Plant-based eating patterns that include beans and legumes support health and disease mitigation through nutritional profile and bioactive compounds including phytochemical. This review focuses on the characteristics of beans and ability to improve obesity-related diseases and associated factors including excess body weight, gut microbiome environment, and low-grade inflammation. Additionally, there are growing data that link obesity to compromised immune response and elevated risk for complications from immune-related diseases. Body weight management and nutritional status may improve immune function and possibly prevent disease severity. Inclusion of beans as part of a plant-based dietary strategy imparts cardiovascular, metabolic, and colon protective effects; improves obesity, low-grade inflammation, and may play a role in immune-related disease risk management.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Dieta Vegetariana/métodos , Fabaceae , Obesidad/prevención & control , Aminoácidos/administración & dosificación , COVID-19/complicaciones , Enfermedades Cardiovasculares/epidemiología , Comorbilidad , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/prevención & control , Proteínas en la Dieta/administración & dosificación , Disbiosis/etiología , Dislipidemias/epidemiología , Dislipidemias/prevención & control , Endotelio Vascular/fisiopatología , Fabaceae/química , Ácido Graso Sintasas , Femenino , Microbioma Gastrointestinal/fisiología , Control Glucémico , Humanos , Hipertensión/epidemiología , Hipertensión/prevención & control , Enfermedades del Sistema Inmune/prevención & control , Inflamación/epidemiología , Inflamación/prevención & control , Masculino , Minerales/administración & dosificación , NADH NADPH Oxidorreductasas , Estado Nutricional , Obesidad/epidemiología , Obesidad/inmunología , Sobrepeso/complicaciones , Phaseolus/química , Ingesta Diaria Recomendada , Factores de Riesgo , Vitaminas/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA